The following are some of the companies belonging to the healthcare sector that reported quarterly earnings and provided an update on their pipeline progress on Monday.
1. Adaptimmune Therapeutics plc (ADAP) is planning to seek FDA approval for its lead product candidate Afami-cel, being developed for the treatment of synovial sarcoma, in the fourth quarter.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com